Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.531NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.21 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.1.396NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.118 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
GJ.1.2.7NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.92 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BF.11.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BN.1.3.11NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.610NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
CH.1.1.18NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BQ.1.21NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.36.35NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.367ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-19336.4Singapore
AY.47 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19324.2Thailand
A.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19324.2Thailand
XBRORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
BN.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
BN.3.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
B.1.619SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19302.9Japan
B.1.619.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19302.9Japan
B.1.1.227SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-19301.9Japan
BN.1.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19294.3Thailand
KP.3.2.5ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-19293.4Japan
GJ.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
BL.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
FL.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
BA.2.7ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-19265.7Germany
HZ.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-19262.8Japan
JL.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-19262.8Japan
BA.4.1.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-19262.2China
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used